Amylyx Pharmaceuticals Inc (AMLX)

Investing Cash Flow

-$149.80M

Quarterly · Period ending: · USD

AMLX logo

AMLX Investing Cash Flow

Latest reported-$149.80M
AMLX Quarterly Cash from Investing (-$151.00K → -$149.80M)
High-resolution chart · PNG

AMLX investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amylyx Pharmaceuticals Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-149,797,000
36,262,000
29,468,000
5,236,000
22,994,000
-43,659,000
64,980,000
38,816,000
-28,961,000
819,000
20,925,000
-108,088,000
123,222,000
55,994,000
-228,180,000
84,041,000
4,462,000
-99,311,000
2,814,000
-49,206,000
0
-14,000
-151,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.